Search results for "ORPHAN DRUG|Designated/Withdrawn|Treatment of melanoma stages IIb through IV." in comments (approximate match)
Showing 1 - 4 of 4 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Tasisulam sodium, previously known as LY573636, were initially recognized by Eli Lilly for their significant antiproliferative activities in solid tumor cell lines, but their mechanism of action was unknown. Subsequent studies have revealed that LY57...
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
Retaspimycin (IPI-504) was previously under development by manufacturer Infinity Pharmaceuticals in conjunction with MedImmune, a part of AstraZeneca. Retaspimycin is a small-molecule inhibitor of heat shock protein 90 (HSP90) with antiproliferative ...